Beam Therapeutics Stock Overlap Studies Midpoint Price over period

BEAM Stock  USD 23.58  0.91  3.72%   
Beam Therapeutics overlap studies tool provides the execution environment for running the Midpoint Price over period study and other technical functions against Beam Therapeutics. Beam Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Midpoint Price over period study function is designed to identify and follow existing trends. Beam Therapeutics overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify Time Period to run this model.

The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Mid-point Price over period is an average of Beam Therapeutics highest and lowest prices attained during the given period.

Beam Therapeutics Technical Analysis Modules

Most technical analysis of Beam Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Beam from various momentum indicators to cycle indicators. When you analyze Beam charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Beam Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Beam Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Beam Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Beam Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Beam Therapeutics's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Beam Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Beam Therapeutics, we also check how macroeconomic factors affect Beam Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2024 (projected)
Dividend Yield0.01190.0106
Price To Sales Ratio5.565.28
Hype
Prediction
LowEstimatedHigh
19.6523.7527.85
Details
Intrinsic
Valuation
LowRealHigh
21.2233.6937.79
Details
Naive
Forecast
LowNextHigh
16.8820.9825.08
Details
18 Analysts
Consensus
LowTargetHigh
60.9767.0074.37
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Beam Therapeutics. Your research has to be compared to or analyzed against Beam Therapeutics' peers to derive any actionable benefits. When done correctly, Beam Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Beam Therapeutics.

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Bonds Directory Now

   

Bonds Directory

Find actively traded corporate debentures issued by US companies
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Gambling Idea
Gambling
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Momentum Idea
Momentum
Invested over 60 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 40 shares
Driverless Cars Idea
Driverless Cars
Invested few shares
Macroaxis Picks Idea
Macroaxis Picks
Invested over 30 shares
Chemicals Idea
Chemicals
Invested over 30 shares
When determining whether Beam Therapeutics is a strong investment it is important to analyze Beam Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Beam Therapeutics' future performance. For an informed investment choice regarding Beam Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Beam Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
To learn how to invest in Beam Stock, please use our How to Invest in Beam Therapeutics guide.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beam Therapeutics. If investors know Beam will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beam Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.58)
Revenue Per Share
4.273
Quarterly Revenue Growth
(0.17)
Return On Assets
(0.09)
Return On Equity
(0.18)
The market value of Beam Therapeutics is measured differently than its book value, which is the value of Beam that is recorded on the company's balance sheet. Investors also form their own opinion of Beam Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Beam Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beam Therapeutics' market value can be influenced by many factors that don't directly affect Beam Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beam Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Beam Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beam Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.